These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 28090673)

  • 21. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
    Dorey L; Hobson S; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
    Toutain PL; Potter T; Pelligand L; Lacroix M; Illambas J; Lees P
    J Vet Pharmacol Ther; 2017 Jan; 40(1):16-27. PubMed ID: 27501187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
    Vilalta C; Giboin H; Schneider M; El Garch F; Fraile L
    J Vet Pharmacol Ther; 2014 Dec; 37(6):542-9. PubMed ID: 24903473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
    de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
    Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
    Nyberg J; Bazzoli C; Ogungbenro K; Aliev A; Leonov S; Duffull S; Hooker AC; Mentré F
    Br J Clin Pharmacol; 2015 Jan; 79(1):6-17. PubMed ID: 24548174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs.
    Papich MG
    Vet Microbiol; 2014 Jul; 171(3-4):480-6. PubMed ID: 24513278
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.